Synopsis
Synopsis
0
CEP/COS
0
KDMF
0
VMF
0
FDF
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Schembl720581
Molecular Weight | 4178 g/mol |
---|---|
Molecular Formula | C183H295N55O53S2 |
Hydrogen Bond Donor Count | 61 |
Hydrogen Bond Acceptor Count | 64 |
Rotatable Bond Count | 146 |
Exact Mass | 4176.1554266 g/mol |
Monoisotopic Mass | 4175.1520718 g/mol |
Topological Polar Surface Area | 1840 Ų |
Heavy Atom Count | 293 |
Formal Charge | 0 |
Complexity | 9780 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 34 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
31
PharmaCompass offers a list of Teriparatide Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Teriparatide Acetate manufacturer or Teriparatide Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Teriparatide Acetate manufacturer or Teriparatide Acetate supplier.
PharmaCompass also assists you with knowing the Teriparatide Acetate API Price utilized in the formulation of products. Teriparatide Acetate API Price is not always fixed or binding as the Teriparatide Acetate Price is obtained through a variety of data sources. The Teriparatide Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Teriparatide Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Teriparatide Acetate, including repackagers and relabelers. The FDA regulates Teriparatide Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Teriparatide Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Teriparatide Acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Teriparatide Acetate supplier is an individual or a company that provides Teriparatide Acetate active pharmaceutical ingredient (API) or Teriparatide Acetate finished formulations upon request. The Teriparatide Acetate suppliers may include Teriparatide Acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Teriparatide Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Teriparatide Acetate DMF (Drug Master File) is a document detailing the whole manufacturing process of Teriparatide Acetate active pharmaceutical ingredient (API) in detail. Different forms of Teriparatide Acetate DMFs exist exist since differing nations have different regulations, such as Teriparatide Acetate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Teriparatide Acetate DMF submitted to regulatory agencies in the US is known as a USDMF. Teriparatide Acetate USDMF includes data on Teriparatide Acetate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Teriparatide Acetate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Teriparatide Acetate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Teriparatide Acetate Drug Master File in Japan (Teriparatide Acetate JDMF) empowers Teriparatide Acetate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Teriparatide Acetate JDMF during the approval evaluation for pharmaceutical products. At the time of Teriparatide Acetate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Teriparatide Acetate suppliers with JDMF on PharmaCompass.
A Teriparatide Acetate written confirmation (Teriparatide Acetate WC) is an official document issued by a regulatory agency to a Teriparatide Acetate manufacturer, verifying that the manufacturing facility of a Teriparatide Acetate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Teriparatide Acetate APIs or Teriparatide Acetate finished pharmaceutical products to another nation, regulatory agencies frequently require a Teriparatide Acetate WC (written confirmation) as part of the regulatory process.
click here to find a list of Teriparatide Acetate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Teriparatide Acetate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Teriparatide Acetate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Teriparatide Acetate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Teriparatide Acetate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Teriparatide Acetate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Teriparatide Acetate suppliers with NDC on PharmaCompass.
Teriparatide Acetate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Teriparatide Acetate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Teriparatide Acetate GMP manufacturer or Teriparatide Acetate GMP API supplier for your needs.
A Teriparatide Acetate CoA (Certificate of Analysis) is a formal document that attests to Teriparatide Acetate's compliance with Teriparatide Acetate specifications and serves as a tool for batch-level quality control.
Teriparatide Acetate CoA mostly includes findings from lab analyses of a specific batch. For each Teriparatide Acetate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Teriparatide Acetate may be tested according to a variety of international standards, such as European Pharmacopoeia (Teriparatide Acetate EP), Teriparatide Acetate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Teriparatide Acetate USP).